SpinTech MRI
SpinTech MRI develops STAGE, an FDA-cleared physics-based MRI post-processing software that accelerates brain scans by up to 30% and produces quantitative outputs including the only FDA-cleared QSM tool. The company licenses the platform to hospitals, health systems, and research institutions via direct enterprise sales and OEM partnerships.
- Company typePrivate
- Founded2017
- HeadquartersBingham Lake, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What SpinTech MRI does
SpinTech MRI is a private medical imaging software company founded in 2017 and headquartered in Bingham Farms, Michigan. The company develops and commercializes STAGE (STrategically Acquired Gradient Echo), an FDA 510(k)-cleared post-processing software platform that accelerates brain MRI acquisition by up to 30% and improves image clarity and contrast by applying advanced MRI physics to fully sampled data from existing 1.5T and 3T scanners across all major manufacturers (Siemens, GE, Philips, Canon). STAGE produces up to 14 output types including enhanced T1, susceptibility weighted imaging (SWI), the only FDA-cleared quantitative susceptibility mapping (QSM) tool, and T1/R2/proton density maps, and integrates between MRI scanners and PACS systems without requiring hardware changes. The company has layered AI on this physics core through STAGE-CMB, an automated cerebral microbleed detection tool, and has announced strategic combinations with Canon AiCE deep learning reconstruction and IMRIS intraoperative MRI.
SpinTech generates revenue through quote-based enterprise software licensing to hospitals and health systems, sold via a direct enterprise sales motion supplemented by OEM and integration partnerships with Canon Medical Systems, IMRIS, and intraoperative MRI platforms. Customer evidence includes academic medical centers (Yale New Haven Hospital, Loma Linda University Hospital), community hospitals (Armstrong County Memorial Hospital), and specialty imaging centers, with the platform deployed at over 50 hospitals and 60 global research sites. The company raised a $6.5M Series A in July 2022 led by cultivate(MD) Focus Fund, with a follow-on investment from the same investor in May 2026, and acquired Magnetic Resonance Innovations in February 2021. The company is led by President & CEO Karen Holzberger and founder E. Mark Haacke, PhD, who serves on the board.
The go-to-market emphasizes dual clinical and financial ROI messaging, citing projected annual revenue increases of $240K per 1.5T system and $320K per 3T system, 3-4 additional scanning slots per magnet per day, and 4-5x more micro-hemorrhages detected in TBI compared to conventional imaging. SpinTech targets radiologists, neuroradiologists, neurosurgeons, neurologists, and healthcare administrators as distinct buyer personas, and participates actively in major industry conferences (RSNA, ASNR) alongside content marketing, webinars, and direct consultation CTAs to drive enterprise pipeline.
SpinTech MRI firmographics
Firmographics- Name
- SpinTech MRI
- Legal name
- SpinTech, Inc.
- Website
- https://spintechmri.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SpinTech MRI develops STAGE, an FDA-cleared physics-based MRI post-processing software that accelerates brain scans by up to 30% and produces quantitative outputs including the only FDA-cleared QSM tool. The company licenses the platform to hospitals, health systems, and research institutions via direct enterprise sales and OEM partnerships.
- Ownership category
- akta.pro rank
SpinTech MRI industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where SpinTech MRI is headquartered
LocationHeadquarters
- HQ city
- Bingham Lake
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SpinTech MRI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- STAGE Software Licensing: SpinTech MRI generates revenue through licensing its STAGE software platform to hospitals and healthcare systems. The software is deployed as a post-processing solution that integrates between MRI scanners and PACS systems. Revenue model appears to be subscription or perpetual license-based with annual maintenance/support components, as the company emphasizes ongoing software updates and support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise licensing |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
SpinTech MRI product offering
Product offeringCore offering
SpinTech MRI develops and licenses the STAGE (STrategically Acquired Gradient Echo) platform, an FDA 510(k)-cleared physics-based MRI post-processing software that accelerates brain MRI scan times by up to 30% while improving image clarity and contrast. The software works with existing 1.5T and 3T MRI scanners from Siemens, GE, Philips, and Canon without requiring hardware changes, generating up to 14 quantitative image outputs including enhanced T1, SWI, QSM, and T1/R2/proton density maps for neurological disease diagnosis.
Product overview
SpinTech MRI offers the STAGE (STrategically Acquired Gradient Echo) platform as its core product, a quantitative MRI software solution that enhances brain imaging efficiency and diagnostic capability. The platform uses physics-based post-processing to accelerate MRI scan times by 30% while improving image quality and providing quantitative outputs. Key use cases span neurological conditions including Parkinson's disease, Alzheimer's/dementia, multiple sclerosis, stroke, traumatic brain injury, and tumor detection. The platform generates up to 14 different image outputs including enhanced T1 weighted, SWI, T2 weighted, and quantitative maps (QSM, T1, R2, proton density). STAGE integrates with existing PACS and MRI scanners from major manufacturers. The company has also developed STAGE-CMB, an automated cerebral microbleed detection tool using AI algorithms. Strategic collaborations with IMRIS and Canon Medical Systems expand the platform's neurosurgical and clinical capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- STAGE (STrategically Acquired Gradient Echo): FDA-cleared quantitative MRI software platform that improves brain MRI image quality and reduces scan times by up to 30%, providing enhanced visualization and quantitative outputs for neurological disease diagnosis.
Products and services
- STAGE (STrategically Acquired Gradient Echo) FDA 510(k)-cleared quantitative MRI software platform that accelerates brain scan times by up to 30% while improving image clarity and contrast, generating multiple image contrasts including enhanced T1, T2, SWI, QSM, and quantitative maps for neurological disease detection. Compatible with Siemens, GE, Philips, and Canon 1.5T and 3T scanners, integrating seamlessly with existing PACS workflows. Targeted at hospitals, health systems, and imaging centers.
- STAGE-CMB (Cerebral Microbleed Detection)
Quantifiable outcome
- 30% reduction in MRI brain protocol scan times, creating 3-4 additional scanning slots per scanner per day and 90-120 minutes of additional scan time per day
- +3 more outcomes
Companies that use SpinTech MRI
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
SpinTech MRI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability3 records
Feature6 records
SpinTech MRI partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered strategic and core.
- IMRISstrategicStrategic collaboration to integrate SpinTech's STAGE AI-driven neuro-imaging software into IMRIS's InVision Surgical Theatre platform for neurosurgery. The combined solution aims to reduce MRI brain exam times by approximately 30% while delivering enhanced 3T-quality resolution from 1.5T systems. The integration targets complex neurosurgical cases including tumor resections and epilepsy treatments, initially available to IMRIS customers in the United States.
- Canon Medical Systems USAstrategicDevelopment collaboration to create a fully quantitative fast MRI solution combining STAGE's physics-based quantitative outputs with Canon's AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction technology. The combined solution generates high-quality 3D brain images with increased SNR on 1.5T scanners with 3T-like resolution. Project aims to expand MRI availability for clinical neuroimaging with significantly shorter exams.
- Yale New Haven HospitalcoreClinical collaboration to examine the impact of STAGE on MRI brain exam times, backlogs, workflows and outcomes in routine clinical use. Yale New Haven Hospital and YNHH Center for Health Care Innovation are conducting an in-depth analysis including multi-institutional review of patient cases comparing existing MRI processes with those using STAGE for Parkinson's, Alzheimer's, dementia, MS, stroke, and other neurological conditions. The collaboration examines impact on efficiency, exam duration, image quality, reporting workflows, scanner throughput, and patient experiences.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
SpinTech MRI competitors and assessment
Company assessmentDirect peers
- icometrix (Qubiit Health): icometrix (now Qubiit Health) offers icobrain, a quantitative brain MRI analysis platform for multiple sclerosis, dementia, and traumatic brain injury — the closest direct competitor to SpinTech's STAGE in brain MRI quantification, with FDA-cleared outputs and a similar hospital/research dual-channel GTM.
- Subtle Medical: Subtle Medical develops AI-based MRI image enhancement software (SubtleMR, SubtleGAD) that accelerates scan times and improves image quality using deep learning — directly comparable to SpinTech's STAGE on value proposition (faster, clearer MRI) but competing via an AI-based rather than physics-based technical approach.
Broad incumbents
- GE HealthCare: GE HealthCare's SIGNAWorks and AIR Recon DL provide AI-based MRI acceleration and image enhancement natively embedded in GE scanners — a broad incumbent competitor that competes with SpinTech's STAGE for MRI efficiency and image quality, though bundled as part of a much larger imaging portfolio.
- Siemens Healthineers: Siemens Healthineers offers Deep Resolve and AI-Rad Companion for MRI acceleration and AI-augmented imaging on its MAGNETOM scanner line — a broad incumbent competing with SpinTech on scanner-throughput economics, with the scale and R&D budget of a global medical imaging leader.
- Philips: Philips provides SmartSpeed AI and its broader radiology informatics portfolio, competing with SpinTech on MRI acceleration and quantitative imaging capabilities across its installed base of Ingenia and Ambition MRI scanners.
- Canon Medical Systems: Canon Medical Systems offers AiCE (Advanced intelligent Clear-IQ Engine) deep-learning reconstruction on its Vantage Galan 3T and other MRI systems — both a strategic SpinTech partner for combined physics+AI solutions and a broad-incumbent competitor with native reconstruction technology on its own scanner hardware.
Emerging players
- Viz.ai: Viz.ai applies AI to neuroimaging workflows, most prominently for large vessel occlusion stroke detection and care coordination, overlapping with SpinTech's neuro focus but centered on triage/workflow rather than image acquisition and quantitative analysis.
- RapidAI: RapidAI provides AI-driven neuroimaging solutions for stroke, aneurysm, and PE triage and quantification, intersecting with SpinTech's neuro focus on speed and quantitative analysis but serving primarily acute stroke workflow use cases rather than routine brain MRI.
- Quibim: Quibim is a quantitative imaging biomarkers company with AI-based analysis for oncology and neurodegeneration MRI — comparable to SpinTech in the quantitative-output value proposition but with a different commercial focus on biomarker discovery and pharma/life sciences partnerships.
Others
- Blackford Analysis: Blackford Analysis provides a developer platform and curated marketplace for medical imaging AI applications, with overlap to SpinTech in deploying third-party imaging algorithms into radiology workflows, though positioned as an enabling infrastructure layer rather than a direct image-enhancement competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
SpinTech MRI social profiles
Digital presenceSpinTech MRI compliance and trust
Trust signalCompliance1 record
SpinTech MRI financial estimates
Financial estimateRevenue estimate
Valuation estimate
SpinTech MRI leadership team
Management profileNumber of profiles
Profiles3 records
SpinTech MRI funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SpinTech MRI M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SpinTech MRI
What does SpinTech MRI do?
SpinTech MRI develops and licenses the STAGE (STrategically Acquired Gradient Echo) platform, an FDA 510(k)-cleared physics-based MRI post-processing software that accelerates brain MRI scan times by up to 30% while improving image clarity and contrast. The software works with existing 1.5T and 3T MRI scanners from Siemens, GE, Philips, and Canon without requiring hardware changes, generating up to 14 quantitative image outputs including enhanced T1, SWI, QSM, and T1/R2/proton density maps for neurological disease diagnosis.
Is SpinTech MRI a public or private company?
SpinTech MRI is a private company. It is classified as venture growth investor backed and is currently operating.
When was SpinTech MRI founded?
SpinTech MRI was founded in 2017. It employs 11 to 50 people.
Where is SpinTech MRI based?
SpinTech MRI is headquartered in Bingham Lake, United States, in the North America region.
How does SpinTech MRI make money?
One revenue line is on record: STAGE Software Licensing.
Who are SpinTech MRI's main competitors?
Direct peers on record are icometrix (Qubiit Health) and Subtle Medical. Broad incumbents are GE HealthCare, Siemens Healthineers, Philips and Canon Medical Systems. Emerging players are Viz.ai, RapidAI and Quibim. Blackford Analysis is listed as an others.
Does SpinTech MRI have an API?
No public API is recorded for SpinTech MRI.
What industry is SpinTech MRI in?
SpinTech MRI's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3826.